Boardroom Alpha
Start trial
8-K primary document
MLSS · Current Report (Form 8-K) · Filed July 29, 2026

Milestone Scientific Inc — 8-K exhibit

ex99-1.htm
Milestone Scientific Inc on Boardroom Alpha

 

Exhibit 99.1

 

Form of Notice of Conversion

of

Promissory Note

(pursuant to Section 5(a) of the Note)

 

Reference is hereby made to that certain Promissory Note of Milestone Scientific Inc. (the “Company”) dated April 8, 2025, as amended, issued to the undersigned holder in the original principal amount of [●] (the “Note”) and on April 20, 2026 partially converted into shares of the Company, issued as part of a series of promissory notes in the aggregate principal amount of $800,000. Terms used herein as defined terms and not defined herein shall have the meaning ascribed thereto in the Note.

 

The undersigned holder of the Note hereby notifies the Company of its election, pursuant to Section 5(a) of the Note, to convert the entire unpaid principal amount of and accrued interest on the Note effective, without any further or other notice to the Company, at such time as the Fair Value of the shares of Common Stock of the Company shall be not less than $0.50 per share; provided that the undersigned shall then be entitled to buy and sell securities of the Company in compliance with the Insider Trading Policy of the Company, including without limitation obtaining any necessary pre-clearance.

 

 
 Name of Holder: [●]

 

 

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer